knowledge
Previous article:
Drug repurposing or repositioning? The language matters
Next article: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
Next article: Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
focus
leisure time
-
Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview
2025-10-01 22:46 -
Medicare coverage of Wegovy, once blocked, now looks possible
2025-10-01 22:15 -
Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline
2025-10-01 22:14 -
Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs
2025-10-01 21:50 -
President Biden's budget: Here's what you might have missed
2025-10-01 21:31 -
Dewpoint Therapeutics lays off staff after losing partnerships
2025-10-01 20:33